
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Ophthalmology
Study Phase : Preclinical
Recipient : Porton Advanced Solutions
Deal Size : Undisclosed
Deal Type : Collaboration
Porton Advanced Teams with TongEYE on iPSC-RPEC Transplantation Therapy
Details : Porton will provide CDMO services to support iPSC-derived retinal pigment epithelium cell therapy program, including CMC development and IND application assistance.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 22, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Ophthalmology
Highest Development Status : Preclinical
Recipient : Porton Advanced Solutions
Deal Size : Undisclosed
Deal Type : Collaboration
